My comment on Katherine Hobson’s blog article at the WSJ titled, “Institute for Safe Medication Practices: Drug Shortages ‘Unprecedented’”
Since the author had a chance to talk to this Michael Cohen, I wish she would have asked more questions about this “authority” that he thinks the FDA should have. Who would be compelled to do what? Who is supposed to be responsible to whom for a “plan?” After all, it’s not clear how a “plan” could help with any of the causes that the article lists. There are a whole lot of unanswered questions that need answers before we think about giving the FDA more power; otherwise it’s just another power grab.